Article Information
- Received August 27, 2010
- Revision received January 5, 2011
- Accepted January 8, 2011
- First published March 2, 2011.
- Version of record published March 2, 2011.
Author Information
- Xiomara Pedre1,
- Fabrizio Mastronardi2,
- Wolfgang Bruck3,
- Gerardo López-Rodas1,4,
- Tanja Kuhlmann5,*, and
- Patrizia Casaccia1,*
- 1Department of Neuroscience and Genetics and Genomics, Mount Sinai School of Medicine, New York, New York 10029,
- 2Inception Research and Therapeutics, Richmond Hill, Ontario L4C 7A9, Canada,
- 3Department of Neuropathology, University Medical Center Göttingen, D-37075 Göttingen, Germany,
- 4Department of Biochemistry and Molecular Biology, University of Valencia, 46100 Burjassot, Valencia, Spain, and
- 5Institute of Neuropathology, University Hospital Münster, D-48149 Münster, Germany
- Correspondence should be addressed to either of the following: Tanja Kuhlmann, Institute of Neuropathology, University Hospital Münster, Domagkstrasse 19, D-48149 Münster, Germany, tanjakuhlmann{at}gmx.de; or Patrizia Casaccia, Department of Neuroscience Genetics and Genomics, Mount Sinai School of Medicine, One Gustave Levy Place, Box 1065, New York, NY 10029, E-mail: patrizia.casaccia{at}mssm.edu
Author contributions
-
↵*T.K. and P.C. contributed equally to this work.
Disclosures
- Received August 27, 2010.
- Revision received January 5, 2011.
- Accepted January 8, 2011.
-
This work was supported by National Institutes of Health (NIH) Grant 2R01NS042925-08, NIH–American Recovery and Reinvestment Act Grant 3R01NS042925-07S1, and National Multiple Sclerosis Society Grant RG-4134 (P.C.); Ministerio de Ciencia y Tecnología Grants CSD2006-00049 and PR2008-0243 (G.L.-R.); and Deutsche Forschungsgemeinschaft Grant KU 1477/5-1 (T.K.). We thank Dr. Jack Antel (Neuroimmunology Unit, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada), the Brain and Spinal Fluid Resource Center, Veterans Affairs West Los Angeles Healthcare Center (Los Angeles, CA), and the Brain-Net Germany supported by Federal Ministry of Health Grant 01GI0505 for providing multiple sclerosis tissue and control samples.
-
Inception Research and Therapeutics has no commerical interest in the work that was conducted by F.M. at The Hospital for Sick Children in Toronto, Canada.
- Correspondence should be addressed to either of the following: Tanja Kuhlmann, Institute of Neuropathology, University Hospital Münster, Domagkstrasse 19, D-48149 Münster, Germany, tanjakuhlmann{at}gmx.de; or Patrizia Casaccia, Department of Neuroscience Genetics and Genomics, Mount Sinai School of Medicine, One Gustave Levy Place, Box 1065, New York, NY 10029, E-mail: patrizia.casaccia{at}mssm.edu
Online Impact
Article usage
In this issue
